8X4
EUROCINE VACCINES NAM.
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. The company is developing Herpes Simplex Virus type 2 and Chlamydia vaccines. Eurocine Vaccines AB (publ) was incorporated in 1999 and is based in Solna, Sweden.
Similar securities
Based on sector and market capitalization
Report issue